Patent assignee · US · COMPANY

BIND Therapeutics, Inc.

27Patents
27Active
27Granted
50Portfolio score

Filing activity: Jun 16, 2009 → Sep 29, 2014 · 2 expiring within 5 years

Most-cited patents

PatentTitleAreaCited byStatus
US8613951B2 Therapeutic polymeric nanoparticles with mTor inhibitors and methods of making and using same Emerging Cross-Sectional Technologies 136 Active
US8603501B2 Cancer cell targeting using nanoparticles Emerging Cross-Sectional Technologies 107 Active
US8603499B2 Cancer cell targeting using nanoparticles Emerging Cross-Sectional Technologies 105 Active
US8617608B2 Drug loaded polymeric nanoparticles and methods of making and using same Emerging Cross-Sectional Technologies 105 Active
US8603500B2 Cancer cell targeting using nanoparticles Emerging Cross-Sectional Technologies 105 Active
US8609142B2 Drug loaded polymeric nanoparticles and methods of making and using same Emerging Cross-Sectional Technologies 102 Active
US8613954B2 Drug loaded polymeric nanoparticles and methods of making and using same Emerging Cross-Sectional Technologies 100 Active
US8563041B2 Therapeutic particles suitable for parenteral administration and methods of making and using same Performing Operations; Transporting 83 Active
US8603534B2 Drug loaded polymeric nanoparticles and methods of making and using same Emerging Cross-Sectional Technologies 83 Active
US8603535B2 Stable formulations for lyophilizing therapeutic particles Emerging Cross-Sectional Technologies 80 Active
US8663700B2 Drug loaded polymeric nanoparticles and methods of making and using same Emerging Cross-Sectional Technologies 77 Active
US8637083B2 Stable formulations for lyophilizing therapeutic particles Emerging Cross-Sectional Technologies 76 Active
US8652528B2 Drug loaded polymeric nanoparticles and methods of making and using same Emerging Cross-Sectional Technologies 73 Active
US9295727B2 Cancer cell targeting using nanoparticles Emerging Cross-Sectional Technologies 31 Active
US8518963B2 Therapeutic polymeric nanoparticle compositions with high glass transition temperature or high molecular weight copolymers Physics 21 Active
US8623417B1 Therapeutic polymeric nanoparticles with mTOR inhibitors and methods of making and using same Emerging Cross-Sectional Technologies 18 Active
US8912212B2 Therapeutic polymeric nanoparticle compositions with high glass transition temperature or high molecular weight copolymers Physics 3 Active
US9358215B2 High throughput fabrication of nanoparticles Emerging Cross-Sectional Technologies 2 Active
US9393310B2 Drug loaded polymeric nanoparticles and methods of making and using same Emerging Cross-Sectional Technologies 2 Active
US8956657B2 Stable formulations for lyophilizing therapeutic particles Emerging Cross-Sectional Technologies 1 Active
US9198874B2 Long circulating nanoparticles for sustained release of therapeutic agents Performing Operations; Transporting 1 Active
US9375481B2 Drug loaded polymeric nanoparticles and methods of making and using same Emerging Cross-Sectional Technologies 1 Active
US9308179B2 Long circulating nanoparticles for sustained release of therapeutic agents Performing Operations; Transporting 0 Active
US9351933B2 Therapeutic polymeric nanoparticles comprising vinca alkaloids and methods of making and using same Human Necessities 0 Active
US9295649B2 Therapeutic polymeric nanoparticle compositions with high glass transition temperature or high molecular weight copolymers Physics 0 Active

Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.